Annual SGA
$13.25 M
-$2.90 M-17.94%
December 31, 2022
Summary
- As of February 10, 2025, ADMP annual SGA is $13.25 million, with the most recent change of -$2.90 million (-17.94%) on December 31, 2022.
- During the last 3 years, ADMP annual SGA has fallen by -$12.04 million (-47.61%).
Performance
ADMP SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$4.03 M
-$749.00 K-15.66%
June 30, 2023
Summary
- As of February 10, 2025, ADMP quarterly SGA is $4.03 million, with the most recent change of -$749.00 thousand (-15.66%) on June 30, 2023.
- Over the past year, ADMP quarterly SGA has dropped by -$172.80 thousand (-4.11%).
Performance
ADMP Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$1.24 B
-$25.24 M-2.08%
June 30, 2023
Summary
- As of February 10, 2025, ADMP TTM SGA is -$1.24 billion, with the most recent change of -$25.24 million (-2.08%) on June 30, 2023.
- Over the past year, ADMP TTM SGA has dropped by -$1.26 billion (-8224.43%).
Performance
ADMP TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ADMP Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -17.9% | -4.1% | -8224.4% |
3 y3 years | -47.6% | -28.7% | -5749.5% |
5 y5 years | -42.0% | -36.6% | -5009.1% |
ADMP Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -17.9% | at low | -15.7% | -37.8% | +18.0% | at low |
5 y | 5-year | -47.6% | at low | -61.5% | -37.8% | +80.3% | at low |
alltime | all time | -48.9% | -90.0% | -61.5% | -100.2% | >+9999.0% | at low |
Adamis Pharmaceuticals Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | $4.03 M(-15.7%) | $14.47 M(-1.2%) |
Mar 2023 | - | $4.78 M(+51.8%) | $14.65 M(+10.6%) |
Dec 2022 | $13.25 M(-17.9%) | $3.15 M(+25.6%) | $13.25 M(+2.0%) |
Sep 2022 | - | $2.51 M(-40.4%) | $12.99 M(-15.0%) |
Jun 2022 | - | $4.21 M(+24.3%) | $15.28 M(-4.6%) |
Mar 2022 | - | $3.38 M(+16.8%) | $16.01 M(-0.8%) |
Dec 2021 | $16.14 M(-19.6%) | $2.90 M(-39.6%) | $16.14 M(-31.9%) |
Sep 2021 | - | $4.79 M(-2.8%) | $23.72 M(+6.7%) |
Jun 2021 | - | $4.93 M(+40.3%) | $22.23 M(-3.1%) |
Mar 2021 | - | $3.52 M(-66.4%) | $22.95 M(-10.0%) |
Dec 2020 | $20.09 M(-20.6%) | $10.47 M(+216.4%) | $25.49 M(+27.5%) |
Sep 2020 | - | $3.31 M(-41.5%) | $19.98 M(-9.1%) |
Jun 2020 | - | $5.65 M(-6.6%) | $21.97 M(-5.8%) |
Mar 2020 | - | $6.05 M(+21.9%) | $23.32 M(-7.8%) |
Dec 2019 | $25.29 M(-2.5%) | $4.97 M(-6.3%) | $25.29 M(-6.0%) |
Sep 2019 | - | $5.30 M(-24.3%) | $26.90 M(-4.4%) |
Jun 2019 | - | $7.00 M(-12.7%) | $28.13 M(+2.3%) |
Mar 2019 | - | $8.02 M(+22.0%) | $27.50 M(+6.0%) |
Dec 2018 | $25.95 M(+13.7%) | $6.58 M(+0.6%) | $25.95 M(+2.9%) |
Sep 2018 | - | $6.53 M(+2.7%) | $25.22 M(+3.2%) |
Jun 2018 | - | $6.36 M(-1.7%) | $24.43 M(+3.0%) |
Mar 2018 | - | $6.47 M(+10.8%) | $23.72 M(+3.9%) |
Dec 2017 | $22.82 M(+33.2%) | $5.84 M(+1.7%) | $22.82 M(+5.8%) |
Sep 2017 | - | $5.75 M(+1.6%) | $21.57 M(+1.9%) |
Jun 2017 | - | $5.66 M(+1.5%) | $21.16 M(+5.3%) |
Mar 2017 | - | $5.57 M(+21.3%) | $20.08 M(+17.3%) |
Dec 2016 | $17.13 M(+90.2%) | $4.59 M(-13.9%) | $17.13 M(+19.3%) |
Sep 2016 | - | $5.34 M(+16.4%) | $14.36 M(+28.8%) |
Jun 2016 | - | $4.58 M(+75.2%) | $11.15 M(+26.3%) |
Mar 2016 | - | $2.62 M(+43.2%) | $8.83 M(-2.0%) |
Dec 2015 | $9.01 M(+97.7%) | $1.83 M(-14.0%) | $9.01 M(+25.4%) |
Sep 2015 | - | $2.13 M(-6.0%) | $7.18 M(+12.2%) |
Jun 2015 | - | $2.26 M(-19.0%) | $6.40 M(+24.3%) |
Mar 2015 | - | $2.79 M(+107.9%) | $5.15 M(+15.3%) |
Dec 2014 | $4.56 M(+34.4%) | - | - |
Sep 2014 | - | $1.34 M(+33.0%) | $4.47 M(+15.0%) |
Jun 2014 | - | $1.01 M(-24.3%) | $3.88 M(+14.6%) |
Mar 2014 | $3.39 M(+68.8%) | $1.34 M(+72.0%) | $3.39 M(+37.0%) |
Dec 2013 | - | $776.40 K(+1.9%) | $2.47 M(+10.5%) |
Sep 2013 | - | $762.10 K(+47.9%) | $2.24 M(+17.4%) |
Jun 2013 | - | $515.20 K(+22.9%) | $1.91 M(+1.4%) |
Mar 2013 | $2.01 M(-24.2%) | $419.20 K(-22.7%) | $1.88 M(+3.6%) |
Dec 2012 | - | $542.00 K(+26.1%) | $1.81 M(-12.8%) |
Sep 2012 | - | $429.70 K(-12.1%) | $2.08 M(-18.7%) |
Jun 2012 | - | $488.80 K(+38.4%) | $2.56 M(-3.5%) |
Mar 2012 | $2.65 M(-21.3%) | $353.30 K(-56.2%) | $2.65 M(+0.0%) |
Dec 2011 | - | $807.20 K(-11.0%) | $2.65 M(-4.4%) |
Sep 2011 | - | $906.60 K(+55.7%) | $2.77 M(-6.4%) |
Jun 2011 | - | $582.20 K(+65.3%) | $2.96 M(-12.1%) |
Mar 2011 | $3.37 M(-1.7%) | $352.20 K(-62.1%) | $3.37 M(-24.3%) |
Dec 2010 | - | $928.70 K(-15.2%) | $4.45 M(+5.3%) |
Sep 2010 | - | $1.10 M(+10.7%) | $4.22 M(+14.7%) |
Jun 2010 | - | $989.10 K(-31.1%) | $3.68 M(+7.6%) |
Mar 2010 | $3.42 M | $1.44 M(+103.5%) | $3.42 M(+48.4%) |
Dec 2009 | - | $705.00 K(+27.6%) | $2.31 M(+23.8%) |
Sep 2009 | - | $552.70 K(-24.2%) | $1.86 M(+18.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2009 | - | $729.60 K(+128.7%) | $1.57 M(+33.5%) |
Mar 2009 | - | $319.00 K(+21.7%) | $1.18 M(-10.9%) |
Dec 2008 | $1.32 M(-26.5%) | $262.10 K(+0.0%) | $1.32 M(-12.7%) |
Sep 2008 | - | $262.00 K(-21.8%) | $1.51 M(-8.6%) |
Jun 2008 | - | $335.00 K(-27.6%) | $1.66 M(-5.2%) |
Mar 2008 | - | $463.00 K(+2.1%) | $1.75 M(-2.8%) |
Dec 2007 | $1.80 M(-64.2%) | $453.60 K(+12.3%) | $1.80 M(+14.7%) |
Sep 2007 | - | $404.00 K(-5.2%) | $1.57 M(-34.5%) |
Jun 2007 | - | $426.00 K(-17.0%) | $2.39 M(-30.4%) |
Mar 2007 | - | $513.00 K(+129.2%) | $3.44 M(-31.6%) |
Dec 2006 | $5.03 M(-43.6%) | $223.80 K(-81.8%) | $5.03 M(-27.7%) |
Sep 2006 | - | $1.23 M(-16.4%) | $6.96 M(-15.1%) |
Jun 2006 | - | $1.47 M(-30.0%) | $8.20 M(+15.4%) |
Mar 2006 | - | $2.10 M(-2.2%) | $7.10 M(-21.2%) |
Dec 2005 | $8.92 M(+39.6%) | $2.15 M(-12.9%) | $9.02 M(-7.3%) |
Sep 2005 | - | $2.47 M(+553.7%) | $9.73 M(+16.5%) |
Jun 2005 | - | $378.00 K(-90.6%) | $8.36 M(-7.2%) |
Mar 2005 | - | $4.02 M(+40.1%) | $9.00 M(+40.9%) |
Dec 2004 | $6.39 M(+33.9%) | $2.87 M(+162.3%) | $6.39 M(+35.2%) |
Sep 2004 | - | $1.09 M(+6.9%) | $4.72 M(+6.1%) |
Jun 2004 | - | $1.02 M(-27.3%) | $4.45 M(-13.4%) |
Mar 2004 | - | $1.41 M(+16.6%) | $5.14 M(+5.6%) |
Dec 2003 | $4.77 M(-30.0%) | $1.21 M(+47.0%) | $4.87 M(-22.4%) |
Sep 2003 | - | $820.00 K(-52.1%) | $6.28 M(+15.2%) |
Jun 2003 | - | $1.71 M(+51.1%) | $5.45 M(-10.3%) |
Mar 2003 | - | $1.13 M(-56.6%) | $6.07 M(-10.9%) |
Dec 2002 | $6.82 M(+68.6%) | $2.61 M(<-9900.0%) | $6.82 M(+30.9%) |
Sep 2002 | - | -$9000.00(-100.4%) | $5.21 M(-15.3%) |
Jun 2002 | - | $2.34 M(+24.6%) | $6.15 M(+31.2%) |
Mar 2002 | - | $1.88 M(+86.7%) | $4.69 M(+15.9%) |
Dec 2001 | $4.04 M(+11.3%) | $1.00 M(+8.1%) | $4.04 M(-11.4%) |
Sep 2001 | - | $929.00 K(+6.1%) | $4.56 M(+1.0%) |
Jun 2001 | - | $876.00 K(-28.9%) | $4.52 M(+4.7%) |
Mar 2001 | - | $1.23 M(-19.3%) | $4.32 M(+18.9%) |
Dec 2000 | $3.63 M(+39.6%) | $1.53 M(+72.3%) | $3.63 M(+34.3%) |
Sep 2000 | - | $886.00 K(+31.8%) | $2.70 M(+11.8%) |
Jun 2000 | - | $672.00 K(+23.1%) | $2.42 M(-0.6%) |
Mar 2000 | - | $546.00 K(-9.0%) | $2.43 M(-6.0%) |
Dec 1999 | $2.60 M(+4.0%) | $600.00 K(0.0%) | $2.59 M(+4.0%) |
Sep 1999 | - | $600.00 K(-12.5%) | $2.49 M(-3.9%) |
Jun 1999 | - | $686.00 K(-2.0%) | $2.59 M(-4.2%) |
Mar 1999 | - | $700.00 K(+40.0%) | $2.70 M(+8.0%) |
Dec 1998 | $2.50 M(+56.3%) | $500.00 K(-28.6%) | $2.50 M(0.0%) |
Sep 1998 | - | $700.00 K(-12.5%) | $2.50 M(+19.0%) |
Jun 1998 | - | $800.00 K(+60.0%) | $2.10 M(+23.5%) |
Mar 1998 | - | $500.00 K(0.0%) | $1.70 M(+6.3%) |
Dec 1997 | $1.60 M(0.0%) | $500.00 K(+66.7%) | $1.60 M(0.0%) |
Sep 1997 | - | $300.00 K(-25.0%) | $1.60 M(-5.9%) |
Jun 1997 | - | $400.00 K(0.0%) | $1.70 M(0.0%) |
Mar 1997 | - | $400.00 K(-20.0%) | $1.70 M(+6.3%) |
Dec 1996 | $1.60 M(-36.0%) | $500.00 K(+25.0%) | $1.60 M(-44.8%) |
Sep 1996 | - | $400.00 K(0.0%) | $2.90 M(+7.4%) |
Jun 1996 | - | $400.00 K(+33.3%) | $2.70 M(+8.0%) |
Mar 1996 | - | $300.00 K(-83.3%) | $2.50 M(+13.6%) |
Dec 1995 | $2.50 M | $1.80 M(+800.0%) | $2.20 M(+450.0%) |
Sep 1995 | - | $200.00 K(0.0%) | $400.00 K(+100.0%) |
Jun 1995 | - | $200.00 K | $200.00 K |
FAQ
- What is Adamis Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual SGA year-on-year change?
- What is Adamis Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly SGA year-on-year change?
- What is Adamis Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals TTM SGA year-on-year change?
What is Adamis Pharmaceuticals annual SGA?
The current annual SGA of ADMP is $13.25 M
What is the all time high annual SGA for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual SGA is $25.95 M
What is Adamis Pharmaceuticals annual SGA year-on-year change?
Over the past year, ADMP annual SGA has changed by -$2.90 M (-17.94%)
What is Adamis Pharmaceuticals quarterly SGA?
The current quarterly SGA of ADMP is $4.03 M
What is the all time high quarterly SGA for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly SGA is $10.47 M
What is Adamis Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, ADMP quarterly SGA has changed by -$172.80 K (-4.11%)
What is Adamis Pharmaceuticals TTM SGA?
The current TTM SGA of ADMP is -$1.24 B
What is the all time high TTM SGA for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high TTM SGA is -$8.40 M
What is Adamis Pharmaceuticals TTM SGA year-on-year change?
Over the past year, ADMP TTM SGA has changed by -$1.26 B (-8224.43%)